Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies.
暂无分享，去创建一个
I. Vergote | N. Concin | M. Mirza | E. Van Nieuwenhuysen | Y. Landesman | S. Shacham | C. Haslund | N. Au | M. Mau-Sørensen | Y. Chai | M. Crochiere | B. Lund | M. Kauffman | S. Han | T. Unger | A. Kranich | T. Rashal | U. Peen | A. Joshi | T. Nøttrup | Z. Umajuridze | J. Shah